Biocon Biologics Expands Insulin Access in Malaysia Kajal Rajput30 Jun 2025 2:57 PM ISTBiocon Biologics Ltd. (BBL) on Monday announced that its Malaysian subsidiary, Biocon Sdn. Bhd., has surpassed the supply of 100 million cartridges of...
US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies Jyoti Kumari30 Jun 2025 2:54 PM ISTBengaluru: The U.S. Food and Drug Administration said on Friday had eliminated risk evaluation and mitigation strategies (REMS), a safety program to...
CDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet Parthika Patel30 Jun 2025 2:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has approved...
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder Jyoti Kumari30 Jun 2025 11:15 AM IST ATLANTA: UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety and efficacy of adjunctive...
Full Inspection of Packaged Water Units in Maharashtra Mandatory, Says FSSAI Jyoti Kumari30 Jun 2025 9:30 AM ISTThane: The Food Safety and Standards Authority of India has ordered a "100 per cent inspection" of packaged drinking water facilities across...
AstraZeneca expands Global Hub in Bangalore with Rs 166 crore investment Ruchika Sharma29 Jun 2025 4:30 PM ISTThe hub is designed to achieve LEED Platinum certification and is currently powered by 75% green energy.
Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months Ruchika Sharma29 Jun 2025 1:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC)...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
USFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies Ruchika Sharma29 Jun 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved label updates for both of its CAR T...
Bayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases Ruchika Sharma29 Jun 2025 11:00 AM ISTBerlin: Bayer has received approval from the European Commission (EC) for a label extension in the European Union (EU) for Eylea 8 mg...
Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal Dr. Divya Colin28 Jun 2025 7:44 PM ISTNew Delhi: Abbott Healthcare has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Safety first: Aurobindo recalls discolored pain relieving drug in US Ruchika Sharma28 Jun 2025 3:30 PM ISTU.S.: In a swift move to protect consumers, Aurobindo Pharma's U.S. unit is recalling more than 4,600 bottles of its pain reliever, Acetaminophen...
